GÈNEVERT

Get ahead of cancer

GÈNEVERT is a biotech startup whose primary mission is to develop persistent molecular targets for effective and relapse-free cancer therapy.

GÈNEVERT™ technology

After years of research, our team has developed an original technology to follow the tumor evolution from the earliest stages and discover the most promising treatment targets.

Learn more

Target cancers

Stemming from a research laboratory specializing in hematological malignancies, our technology was initially developed and optimized in a model of Burkitt lymphoma.

We have now expanded our scope to include the three major subtypes of lung cancer and several rare childhood tumors.

Learn more

3

PROGRAMMES

11000

DAYS OF RESEARCH

1

AIM